Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Leaders From the Oncology Industry Convene at the Economist Events' War on Cancer 2016 to Explore Solutions to the Mismatch in Progress and Delivery in Cancer Care


News provided by

Consilium Strategic Communications

08 Dec, 2016, 09:30 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, December 8, 2016 /PRNewswire/ --

The Economist Events' second annual War on Cancer 2016, held in London on Tuesday, was host to some of the highest profile leaders in oncology from across the field and around Europe. Discussions at the summit explored innovative approaches to cancer prevention and treatment, solutions to overcome shortcomings in delivery and examples of best practice and opportunities for cross-sectoral collaboration.

The event gathered over 150 global influencers, government ministers, private sector CEOs, academia, healthcare professionals and high-level national and international media from around Europe.

Andreas Penk, regional president oncology, international developed markets, Pfizer commented: "We see more and more possibilities on the horizon to cure specific cancers. Personalized medicine and immuno-oncology will lead the way and bridge until the next generation of medicine is ready. Curing is a game changer. All involved parties should start to work together on innovative solutions in care, contracting, pricing, and regulatory to make sure we translate the possible into reality."

Mahiben Maruthappu, co-founder, NHS Innovation Accelerator, said: " Whilst great technological advancements have already been made in the war against cancer, it is of great importance that research and development continues in order to continue to deliver innovative new treatments.This event provides a platform for global leaders from across the industry to discuss what the future might hold and ensure health care systems are prepared."

Speakers offered contrasting and thought-provoking commentary on how to deal with the most pressing of sector trends leading to lively debate amongst the delegates. Topics covered included optimising national cancer control plans, cancer in the context of health care systems, the promise and peril of health-tech convergence and mobilising action and inspiring change.

Key speakers at the summit included: 

  • Matti Aapro, board member, European Cancer Organisation
  • Cary Adams,chief executive officer, Union for International Cancer Control
  • Tit Albreht, coordinator, Cancer Control Joint Action (CanCon);head, National Institute of Public Health of Slovenia
  • Kathi Apostolidis, vice-president, European Cancer Patient Coalition (ECPC); president of Executive Committee, Hellenic Cancer Federation - ELL.O.K
  • Frauke Becker, research associate, Institute of Health and Society, Newcastle University
  • John Bell, regius professor of medicine, University of Oxford; chairman, Office for Strategic Coordination of Health Research (OSCHR)
  • Jurgi Camblong,chief executive officer and co-founder, Sophia Genetics
  • Josep Figueras, director, European Observatory on Health Systems and Policies; head, World Health Organization European Centre on Health Policy
  • George Freeman, member oparliament for Mid Norfolk and chair, Prime Minister's Policy Board
  • David Khayat, head of the department of Oncology, Pitié-Salpêtrière Hospital and professor of Oncology, University Pierre and Marie Curie
  • Bryony Kimmings, creator of the musical 'A Pacifist's Guide to the War on Cancer'
  • Jane Maher, chief medical officer, Macmillan Cancer Support
  • Lydia Makaroff, director, European Cancer Patient Coalition
  • Mahiben Maruthappu, co-founder, NHS Innovation Accelerator
  • Maya Martinez - Davis, senior vice-president, Global Head of Oncology Franchise, Merck KGaA
  • Vivek Muthu, chair, Economist Intelligence Unit Healthcare
  • Annie Pannelay, healthcare principal, Economist Intelligence Unit
  • Terje Peetso,policy officer, directorate-general communications networks, content and technology, European Commission
  • Andreas Penk, regional president oncology, international developed markets, Pfizer
  • Jem Rashbass, national director for disease registration, Public Health England
  • Gunnar Saeter, professor and head of institute, Institute for Cancer Research - Olso University Hospital
  • Katherine Smith, reader- global public health unit, University of Edinburgh
  • Zhen Su, vice-president, US Oncology Medical Affairs, EMD Serono
  • Richard Sullivan, professor of cancer and global health, King's College London; Director, Institute of Cancer Policy
  • Frans van Houten, chief executive and chairman, Philips
  • Paul Workman,chief executive officer and president, The Institute of Cancer Research London; Harrap Professor of Pharmacology and Therapeutics

Tweet via @EconomistEvents #WaronCancer

Press enquiries

Lindsey Neville

Email: waroncancer2016@consilium-comms.com

Tel: +44 (0)20 3709 5700


-ENDS-

For general queries or further information about the event please call +44 (0) 207 576 8118 or e-mail emeaevents@economist.com

Want more from The Economist Events?
Join us on Twitter: @EconomistEvents

About The Economist Events
The Economist Events' philosophy is to tackle issues with a forward-looking, uniquely global perspective. We aim to create events for the intellectually curious: people who enjoy ideas and who are passionate about the issues that define our world.

Attend our events: http://www.economist.com/events-conferences/emea

Founding sponsor: Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are committed to changing survival expectations in hard-to-treat cancers and the way patients live with cancer through our pioneering, comprehensive Immuno-Oncology portfolio and clinical program as well as research collaborations with academia and biotech companies.

Founding sponsor: Merck
Merck discovers, develops, manufactures and markets prescription medicines of both chemical and biological origin in specialist indications. We have an enduring commitment to deliver novel therapies in our core focus areas including oncology and immuno-oncology; supporting patients with cancer. Merck has a robust pipeline of potential therapies in oncology, immuno-oncology and immunology.

Gold sponsor: Pfizer Oncology
Pfizer Oncology is focused on helping to redefine life with cancer. By maximizing our internal scientific resources and collaborating with other companies, government and academic institutions, we bring together the brightest and most enterprising minds to take on the toughest cancers, helping speed breakthrough treatments to patients around the world.

Silver Sponsor: Novartis
Novartis Oncology is a global leader in providing a broad range of innovative therapies to help improve the lives of cancer patients.

Silver Sponsor: Varian Medical Systems
Global manufacturer of medical devices and software for treating cancer with radiotherapy, radiosurgery, proton therapy and brachytherapy.

About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in providing trusted, healthcare-focused strategic IR and financial PR counsel to corporations, Boards, senior decision makers and executives. From offices in Europe and USA, Consilium Strategic Communications' senior team provides cross-border comprehensive financial and corporate healthcare communications advice to some of the world's most prominent corporations around-the-clock. For more information, please visit our website at http://www.consilium-comms.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.